Bio Essence (BIOE) Other Working Capital Changes (2021 - 2026)
Bio Essence (BIOE) recorded quarterly Other Working Capital Changes of $237500.0 in Q1 2026, up 281.07% quarter-over-quarter from -$131168.0 in Q4 2025, and up 185.95% on a YoY basis from $83056.0 in Q1 2025.
Bio Essence (BIOE) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Bio Essence's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $237500.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 185.95% year-over-year to $237500.0; the TTM figure through Mar 2026 stood at $87541.0 (up 5.4% YoY), while the FY2025 annual figure was -$66903.0, down 42.04% from the prior year.
- Other Working Capital Changes was $237500.0 for Q1 2026 at Bio Essence, up from -$131168.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $237500.0 in Q1 2026 to a low of -$209515.0 in Q3 2022.
- Historically, Other Working Capital Changes has averaged -$4159.4 across 5 years, with a median of -$1817.5 in 2023.
- The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes soared 3598.34% in 2022, then sank 24689.47% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $178905.0 in 2022, then plunged by 178.98% to -$141301.0 in 2023, then surged by 102.44% to $3445.0 in 2024, then plunged by 3907.49% to -$131168.0 in 2025, then jumped by 281.07% to $237500.0 in 2026.
- The last three Other Working Capital Changes figures came in at $237500.0 (Q1 2026), -$131168.0 (Q4 2025), and $43161.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Bio Essence | - | - | 319,353.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237,500.00 |
| Mar 31, 2026 | 237,500.00 |
| Dec 31, 2025 | -131,168.00 |
| Dec 31, 2025 | -131,168.00 |
| Sep 30, 2025 | 43,161.00 |
| Sep 30, 2025 | 43,161.00 |
| Jun 30, 2025 | -61,952.00 |
| Jun 30, 2025 | -61,952.00 |
| Mar 31, 2025 | 83,056.00 |
| Mar 31, 2025 | 83,056.00 |
| Sep 30, 2024 | 3,445.00 |
| Sep 30, 2024 | 3,445.00 |
| Jun 30, 2024 | -3,445.00 |
| Jun 30, 2024 | -3,445.00 |
| Mar 31, 2024 | -47,100.00 |
| Mar 31, 2024 | -47,100.00 |
| Dec 31, 2023 | -141,301.00 |
| Dec 31, 2023 | -141,301.00 |
| Sep 30, 2023 | -41,195.00 |
| Sep 30, 2023 | -41,195.00 |